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Adamson S Muulab & Manuela De Allegria
Introduction
Improving health-care quality is essential to health systems 
strengthening.1 Financial, material and human resource limita-
tions challenge low- and middle-income countries to sustain 
satisfactory health-care quality performance.2 Health-care 
quality improvement strategies differ in focus. Some strategies 
focus more on health workers’ performance and the immediate 
micro-context in which health workers provide care. Other 
strategies focus more on the health system’s macro-context 
to address financial and fiscal constraints, inefficient resource 
allocations, limited donor coordination or ineffective health 
sector regulation.3–5
Performance-based financing schemes are health fi-
nancing strategies that link economic aspects of health care 
provision (macro-context) directly to bottlenecks at the 
frontline of actual service delivery (micro-context) aiming 
to improve health-care quality. 6,7 The schemes commonly tie 
payments to front-line service providers (health worker or 
facility) to predefined clinical and/or structural performance 
measures.8 Performance-based payments are usually man-
aged and directly invested in further service improvements 
by facilities. Moving some fiscal decision-making towards 
front-line providers allows for additional mechanisms to 
overcome day-to-day limitations in service provision (such as 
inadequate supplies or low staff motivation) faced by health 
facilities.9,10 Many low- and middle-income countries have 
adopted performance-based financing schemes because of 
their potential to optimize both financial management and 
service quality (micro-context).11–13 The schemes may also of-
fer more sustainability to health-care quality improvements 
by strengthening or redefining responsiveness and account-
ability across various service providers and health-system 
actors (macro-context).10,14
Failure to maintain essential service inputs, such as 
adequate staffing, drug procurement, equipment repair, etc. 
risks the overall success of health-care quality improvement 
programmes.15,16 Health-care quality depends on adequate 
human resource and supply chain mechanisms for procure-
ment of drugs and supplies, particularly in systems exposed 
to extreme resource constraints.17 In many low- and middle-
income countries, central-level health officials are responsible 
for maintaining drug stocks, essential equipment and adequate 
staffing across health facilities, and are thus ultimately liable 
for service quality at the periphery.18 Therefore, centrally 
organized health systems may benefit from strategies that 
introduce more decentralized structures of decision-making, 
responsiveness and accountability.
While performance-based financing schemes in principle 
are designed to help health workers and service managers to 
achieve better health-care quality outcomes, their actual effect 
in doing so remains unclear.7,9 Recent performance-based 
financing evaluations in Afghanistan19 and Burundi20 failed 
to detect strong effects of their schemes on health facilities’ 
ability to secure essential drugs and supplies. A Tanzanian 
scheme directly providing incentives for facilities to manage 
essential drugs and supplies failed to prevent stock-outs of 
essential equipment, medicines and commodities.21 The study 
concluded that incentives provided to facilities to improve 
quality-of-care performance that are tied to drug and sup-
ply management cannot overcome systemic shortcomings, 
such as inadequate supply chain structures.21 Conversely, a 
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scheme in Zambia provided incentives 
to health facilities, which were tied to a 
programme on essential drug and sup-
ply management. The scheme enabled 
participating facilities to use financial 
rewards gained for positive perfor-
mance to purchase additional drugs, 
which successfully reduced subsequent 
stock-outs.22 Yet generalized evidence on 
performance-based financing schemes’ 
effects on improving health-care service 
management processes remains limited. 
This is partially because many schemes 
narrowly focus on service utilization or 
the clinical aspect of health-care quality, 
often overlooking elements directly tied 
to the structural aspect.23
We evaluated a performance-based 
financing scheme in Malawi to further 
understand the potential of such a 
scheme to improve both clinical (i.e. 
adherence to obstetric care treatment 
protocols) and structural (i.e. provision 
of essential drugs, supplies and equip-
ment) aspects of health-care that have 
an effect on providing quality care.
Methods
Study Setting
Malawi has a centralized tax-based 
health system that receives significant 
external donor support.24,25 In 2010, 
basic emergency obstetric care was 
provided free of charge by 98 (90%) 
public and contracted not-for-profit 
health facilities nationwide.25 Public 
health-care facilities receive general 
budget allocations from the Ministry 
of Health for infrastructure, equipment 
and salaries.26 District health manage-
ment teams receive additional budget 
allocations from the Ministry of Local 
Government and Rural Development to 
procure drugs and supplies from central 
medical stores for all public facilities 
within their districts.25,27
Malawi’s health system faces two 
major challenges. First, the country has 
inadequate human resources and suf-
fers from shortages of qualified health 
workers, poor remuneration, limited 
career opportunities and insufficient 
supervision and training opportuni-
ties.28,29 Second, it has a wide-spread lack 
of essential equipment at health centres 
with recurrent stock-outs of drugs and 
consumables.30,31 Consequently, public 
facilities struggle to provide quality 
health-care services.32 To address some 
of these limitations and to meet the mil-
lennium development goals 4 and 5, to 
reduce child and maternal mortality, the 
Malawian Ministry of Health introduced 
the Results Based Financing for Mater-
nal and Neonatal Health (RBF4MNH) 
Initiative in 2013 at several emergency 
obstetric care facilities. Similar to other 
performance-based incentive schemes, 
the initiative provides financial rewards 
for maternal care providers and dis-
trict health management teams upon 
meeting defined performance goals 
(performance-based incentives). It also 
provides conditional cash transfers (fi-
nancial rewards) for pregnant women 
upon meeting defined compliance 
targets.1 Details about the initiative and 
its implementation design are presented 
in Box 1.
Study design
This paper focuses on the performance-
based financing component of the initia-
tive and assesses its effects on maternal 
and newborn health service quality. 
The study is part of a larger impact 
evaluation that uses a non-randomized 
controlled before and after study design 
with independent controls.34 The inter-
vention sample for this study initially 
consisted of all 18 facilities contracted 
by the initiative at the beginning of 
phase I: four public district hospitals, 
and 14 public health centres providing 
at least basic emergency obstetric care. 
The control sample included all health 
facilities within the same study districts 
that were not, or not yet, enrolled in the 
initiative at baseline: one mission hos-
pital, two private and 12 public health 
centres providing basic emergency ob-
stetric care. Several months prior to the 
last data collection round, five previous 
control facilities (a mission hospital, one 
private and three public health centres) 
were contracted by the initiative (phase 
II) and thus moved into the study’s in-
tervention arm. Data were collected at 
three time-points: before the initiative 
was implemented (March/April 2013) 
used as baseline, at mid-point (June/July 
2014) and at the end (June/July 2015). In 
addition, at each time point we identi-
fied a small number of pregnant women 
giving birth per each sampled facility 
using a convenience-sampling approach.
Outcome indicators
We measured the scheme’s effect on 
quality using two sets of performance 
outcomes: structural performance and 
clinical performance (Box 2). For struc-
tural performance, we assessed the avail-
ability and functionality of service input 
elements, such as equipment, drug and 
supply items included in the initiative’s 
tracer lists at each sampled facility. To 
measure effects on clinical performance, 
we observed the following processes: (i) 
routine care activities required to identify 
respective emergency conditions; (ii) 
the overall number of pregnant women 
monitored by partograph; (iii) the com-
pleteness of partograph documentation; 
(iv) a set of common routine infection 
prevention measures; (v) oxytocin ad-
Box 1. Malawi’s Results-Based Financing for Maternal and Neonatal Health Initiative: 
implementation design
The Results-Based Financing for Maternal and Neonatal Health Initiative was introduced in 
Malawi in April 2013 to improve the quality of facility-based care provided to women and 
newborns during and within 48 hours after delivery. The initiative was implemented in selected 
emergency obstetric care facilities across four districts (Balaka, Dedza, Mchinji and Ntcheu). Similar 
to other performance-based incentive programmes, the initiative combines financial rewards 
for maternal care providers and district health management teams upon meeting defined 
performance goals (performance-based incentives) with conditional cash transfers (financial 
rewards) for pregnant women upon meeting defined compliance targets.33 Across the four 
districts, the initiative contracted 18 health facilities (four hospitals and 14 health centres) during 
phase I (April 2013–October 2014) and then expanded to include a total of 28 health facilities 
(5 hospitals and 23 health centres) during phase II (ongoing until 2017). Enrolment of facilities 
into the initiative was non-random and was based on performance of emergency obstetric 
care signal functions, functionality of referral system, geographical emergency obstetric care 
coverage and catchment population size. Each enrolled facility received initial start-up financial 
support conditional on need related to immediate infrastructural requirements (i.e. potable 
water, electricity, waste disposal, building structures, etc.). Incentives for facilities are largely tied 
to clinical and general service management performance; district health management team 
incentives are largely tied to equipment maintenance and drug supply management across 
all facilities within each district. At least 30% of received payments are re-invested to further 
improve health care quality at district and facility levels, while the remaining portion is directly 
shared among staff as personal bonuses.
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ministration; and (vi) other essential 
elements of active management of third 
stage labour (AMTSL), such as controlled 
cord traction, uterine massage, complete-
ness check of placenta and estimation of 
overall blood loss.
Data collection
We measured changes in the outcome 
variables (Box 2) over the study period 
using two different survey instruments: 
(i) facility inventory checklists to collect 
information on structural performance; 
and (ii) an observation checklist to 
document non-participant observations 
of routine labour cases to assess birth 
attendants’ clinical performance.35 We 
trained research assistants with a back-
ground in midwifery to observe and 
record routine clinical care processes 
in uncomplicated labour presenting 
to a facility during a 5-day visit, long 
enough to observe an adequate num-
ber of deliveries. We observed only for 
3 days during baseline data collection. 
Clinical performance was measured 
against national midwifery standards.36 
All uncomplicated labour case observa-
tions began when a woman in labour 
was taken to a maternity unit and ended 
two hours after childbirth. To ensure 
data completeness and accuracy, check-
lists were designed to prompt research 
assistants to complete or indicate any 
missing information during and im-
mediately after data collection. Written 
informed consent was obtained from 
both patients and birth attendants before 
observation. Both survey instruments 
were used at all study facilities during 
each of the three data collection time 
points. We observed 33 health facilities 
(23 intervention facilities and 10 control 
facilities) and 401 pregnant women 
across four districts. Table 1 presents 
a summary of the number of sampled 
facilities and pregnant women observed 
at each data collection time.
Analytical approach
To estimate the scheme’s effect on each 
outcome variable, we used a difference-
in-differences (DiD) linear regression 
model.37
Box 2. Performance indicators and related measures of the performance-based financing scheme in Malawi
Clinical performance indicators and process measuresa
A. Proportion of pregnant women with unknown HIV status giving birth in the facility who are tested and treated (if positive) with PMTCT medicines.
1. Birth attendant verifies patient’s HIV status using antenatal history review.
B. Proportion of pregnant women giving birth in the facility and show signs of pre-eclampsia or eclampsia who received magnesium-sulfate.
1. Birth attendant asks patient for symptoms related to pre-eclampsia.
2. Birth attendant checks for signs of pre-eclampsia.
C. Proportion of partographs completed and appropriately filled among women giving birth in the facility.
1. Birth attendant monitors partograph during first stage labour
2. Birth attendant documents record of complete partograph.
D. Implementation of at least one infection control action per reporting period.
1. Birth attendant performs hand hygiene before patient contact.
2. Birth attendant correctly uses sterile gloves during vaginal examination and stage 2 labour.
3. Birth attendant decontaminates perineum before vaginal examination and stage 2 labour.
4. Birth equipment is set up in sterile manner before the beginning of stage 2 labour.
E. Proportion of pregnant women giving birth in the facility who receive oxytocin in third stage of labour.
1. Birth attendant performs medical AMTSL.
2. Birth attendant performs practical AMTSL.
3. Birth attendant confirms success of AMTSL.
Structural performance indicators and input measuresb
A. Proportion of facilities with functional operational maternity equipment.
1. Availability of routine equipment (delivery kits, suturing kits, cord clamps, manual suction device with tubing).
2. Availability of vital sign assessment equipment (blood pressure machine, stethoscope, thermometer, fetoscope).
3. Availability of emergency equipment (newborn size bag valve with mask, vacuum extractor).
4. Availability of ancillary equipment (sterilizer, number of delivery beds, number of obstetric examination beds).
B. Proportion of at least a 1-month supply of essential maternal and newborn health medicines and commodities at all facilities in the district.
1. Proportion of facilities with stocks of antibiotics (ampicillin, benzyl penicillin, co-trimoxazole).
2. Proportion of facilities with stocks of emergency obstetric care drugs (magnesium sulfate, diazepam, oxytocin).
3. Proportion of facilities with stocks of isotonic fluids (Ringer’s lactate, normal saline, dextrose 5% saline).
4. Proportion of facilities with stocks of pain control (paracetamol, pethidine).
5. Proportion of facilities with stocks of PMTCT drugs (nevirapine syrup, ART regimen 5Ac).
6. Proportion of facilities with stocks of ancillary items (urine protein testing strips).
AMTSL: active management of third stage labour; ART: anti-retroviral treatment; HIV: human immunodeficiency virus; PMTCT: prevention of mother-to-child 
transmission of HIV.
a  At birth attendant level.
b  At facility level.
C  Antiretroviral therapy with tenofovir, disoproxil, fumarate, lamivudine and efavirenz.
Note: Based on indicators for the Results-Based Financing for Maternal and Neonatal Health Initiative.
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The model is as follows:
Yi = β0 + β1 t1i + β2 T1i + β3 t1i*T1i + β4 
t2i + β5 T2i + β6 t2i*T2i + βk Xk,i + ρm,c + 
εit 
where, Yi represents our outcome 
variables, (structural or clinical perfor-
mance); β0 is the average frequency of 
observations among controls at baseline; 
t is a dummy variable indicating the 
observation time point, with t1 being 
observation at mid-term and t2 being 
observation at end-term; T is another 
dummy variable that indicates the treat-
ment time point, with T1 being treat-
ment distribution during phase I (April 
2013–October 2014) and T2 being 
treatment distribution at phase II (from 
November 2014 onwards). T*t denotes 
the interaction between treatment and 
time point, where T1*t1 denotes interac-
tion at mid-term and T2*t2 at end-term; 
Xk,i denotes potential confounders; ρ is 
within-cluster correlation; m is the num-
ber of clusters and c denotes the number 
of individual observations. The overall 
effect size estimate at end-term is rep-
resented by β6, which served as overall 
effect estimate for the entire initiative.
We adjusted all models for potential 
confounders, i.e. facility type (hospital 
versus health centre) and ownership 
(public versus faith-based). Models used 
in analysing clinical performance were 
further adjusted for duration of stage 1 
labour (accounting for late presenting 
women unlikely to be monitored by 
partograph), number of birth attendants 
available during a case (accounting 
for workload constraints) and birth 
attendants’ participation in in-service 
trainings (accounting for recent skill 
changes independent of the scheme). We 
further controlled clinical performance 
for clustering effects at the level of the 
facility. Given the relatively small sample 
sizes, we used bootstrapping to derive 
more robust estimates of the underlying 
population parameters.38 We used Stata 
version 12.1 (StataCorp. LP, College 
Station, United States of America) for 
all statistical analyses.
Ethical approval was obtained from 
the College of Medicine Research and 
Ethics Committee at the University of 
Malawi and the Ethical Committee of 
the Medical Faculty at the University of 
Heidelberg.
Results
Table 2 summarizes changes and ef-
fect sizes for equipment maintenance. 
Positive DiD coefficients indicate a 
comparatively larger increase in avail-
ability of operational equipment at 
intervention facilities. We found statisti-
cally significant positive effects for nearly 
all essential equipment items related 
to routine obstetric care and vital sign 
recording. For items related to emer-
gency and ancillary equipment, only a 
few items showed a significant positive 
effect (vacuum extractors, sterilizers 
and examination beds). We observed no 
significant effects for delivery beds. For 
blood pressure machines and newborn 
resuscitation equipment, improvements 
in both intervention and control facilities 
over time led to no significant change.
The scheme’s effects on drug and 
consumable stocks varied greatly (Ta-
ble 3). We observed statistically sig-
nificant positive effects for ampicillin, 
oxytocin, dextrose 5% saline solution, 
pethidine, and human immunodefi-
ciency (HIV) drugs used for prevention 
of mother-to-child transmission. We 
observed significant negative effects 
for benzyl penicillin, normal saline and 
Ringer’s solution. In both intervention 
and control facilities, diazepam and 
urine testing strip stocks improved but 
stocks for magnesium sulfate worsened.
The effects on clinical performance 
were diverse (Table 4). Positive, but 
non-significant effects were observed for 
review of pre-eclampsia symptoms and 
timely set-up of sterile birth equipment. 
Negative effects were found for parto-
graph monitoring and AMTSL. Initially, 
parallel improvements across interven-
tion and control facilities occurred for 
examination of pre-eclampsia signs, 
partograph documentation, infection 
prevention techniques during vaginal 
examinations and births, as well as medi-
cal and practical elements of AMTSL.
Discussion
Our findings demonstrate that perfor-
mance incentives directed to a range 
of health system actors beyond the ac-
tual frontline providers can affect health 
service quality positively. In our study, 
direct district level involvement not only 
improved supply management at inter-
vention facilities, but likely produced 
additional benefits to control facilities.
Our findings indicate an overall 
positive impact on both equipment 
maintenance and drug stocks as a result 
of the incentives provided through the 
scheme. Though limited, this evidence 
suggests that performance-based fi-
nancing may effectively sustain service 
inputs and processes once incentives are 
set across relevant health system levels. 
Qualitative evidence from interviews 
with the initiative’s district health and fa-
cility managers illustrate that local adop-
tion has led to further decision-making 
by managers about resource allocation 
to extend beyond the initiative.39 The 
decision allowed facilities not included 
in the performance-based financing ini-
tiative to receive procurement support.39 
This local adoption effect on equipment 
availability was also demonstrated by the 
Salud Mesoamérica initiative – a results-
Table 1. Sample size for intervention and control facilities, by data collection time 
point, Malawi, 2013–2015
Data collection time point Facility type, no.
Interventiona Control All
Facilities    
Baseline 17 14 31
Mid-term 18 13 31
End-term 23 10 33
Pregnant women    
Baseline 63 24 87
Mid-term 106 58 164
End-term 131 19 150
a  The intervention was performance-based financing, a scheme where financial rewards for maternal care 
providers and district health management teams were provided upon meeting defined performance 
goals (performance-based incentives), and conditional cash transfers (financial rewards) were provided for 
pregnant women, upon meeting defined compliance.
Bull World Health Organ 2017;95:491–502| doi: http://dx.doi.org/10.2471/BLT.16.178202 495
Research
Maternal and newborn health care, MalawiStephan Brenner et al.
Table 2. Impact of performance-based financing scheme on equipment maintenance, Malawi, 2013–2015
Observed outcome variable by facility 
type
Health facilities with equipment item available in operational 
state at time of visit
Overall effect size
Baseline No.a (%) Mid-term No.a (%) End-term No.a (%) DiD (% point) P
Routine obstetric care equipment
Delivery kits
    Interventionb 10 (60) 17 (97) 20 (87) 29 < 0.01
    Control 8 (60) 8 (59) 6 (58)   
Suturing kits      
    Interventionb 1 (7) 11 (61) 13 (55) 49 < 0.01
    Control 3 (25) 3 (2) 4 (45)   
Cord clamps
    Interventionb 8 (48) 9 (49) 14 (60) 24 0.05
    Control 8 (58) 6 (48) 5 (45)   
Manual suction device
    Interventionb 17 (9) 4 (23) 13 (55) 43 < 0.01
    Control 4 (25) 0 (0) 2 (21)   
Vital sign recording equipment
Blood pressure machine
    Interventionb 11 (62) 14 (75) 18 (80) −2 0.85
    Control 6 (44) 7 (55) 6 (64)   
Stethoscope      
    Interventionb 6 (34) 14 (75) 20 (88) 52 < 0.01
    Control 10 (71) 9 (69) 8 (75)   
Thermometer      
    Interventionb 12 (68) 14 (75) 22 (98) 19 0.03
    Control 10 (74) 9 (70) 9 (87)   
Fetoscope      
    Interventionb 11 (63) 8 (42) 16 (70) 19 0.09
    Control 14 (99) 5 (42) 9 (86)   
Emergency obstetric care 
equipment
Newborn size bag valve mask
    Interventionb 11 (67) 4 (21) 17 (75) −6 0.58
    Control 8 (56) 0 (1) 7 (71)
Vacuum extractor
    Interventionb 9 (53) 10 (55) 19 (82) 43 < 0.01
    Control 8 (58) 2 (14) 4 (43)
Ancillary equipment
Sterilizer
    Interventionb 9 (55) 13 (73) 17 (75) 27 0.02
    Control 11 (77) 7 (53) 7 (69)
At least 2 delivery beds
    Interventionb 19 (87) 16 (90) 20 (87) −6 0.51
    Control 11 (81) 10 (77) 9 (87)
At least 1 obstetric examination bed
    Interventionb 6 (34) 17 (93) 22 (96) 33 0.01
    Control 6 (44) 10 (79) 7 (73)
DiD: difference-in-differences estimate.
a  Frequencies are estimates based on the regression analysis.
b  The intervention was performance-based financing, a scheme where financial rewards for maternal care providers and district health management teams were 
provided upon meeting defined performance goals (performance-based incentives), and conditional cash transfers (financial rewards) were provided for pregnant 
women, upon meeting defined compliance.
Note: DiD estimates are calculated across years 1 and 2.
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Table 3. Impact of performance-based financing on availability of essential drug and consumables stocks, Malawi, 2013–2015
Observed outcome variable by facility type Health facilities with item in stock at time of visit Overall effect size
Baseline, No.a (%) Mid-term, No.a (%) End-term, No.a (%) DiD, (% 
point)
P
Antibiotics 
Ampicillin
    Interventionb 0 (0) 0 (0) 6 (26) 47 < 0.01
    Control 3 (22) 0 (0) 2 (15)
Benzyl penicillin
    Interventionb 13 (74) 17 (94) 11 (47) −20 0.07
    Control 12 (86) 9 (70) 8 (75)
Co-trimoxazole
    Interventionb 15 (86) 16 (86) 20 (89) −7 0.46
    Control 11 (79) 10 (73) 9 (89)
Emergency drugs 
Magnesium sulfate
    Interventionb 16 (92) 13 (71) 17 (75) 9 0.52
    Control 10 (71) 8 (63) 5 (46)
Diazepam
    Interventionb 7 (43) 7 (39) 15 (63) −10 0.51
    Control 5 (37) 4 (28) 7 (67)
Oxytocin
    Interventionb 17 (99) 10 (57) 23 (100) 31 < 0.01
    Control 11 (77) 7 (56) 5 (51)
Emergency obstetric care equipment 
Ringer’s lactate
    Interventionb 8 (50) 12 (65) 14 (61) −26 0.03
    Control 3 (21) 5 (36) 6 (61)
Normal saline
    Interventionb 12 (69) 16 (87) 17 (72) −30 < 0.01
    Control 6 (41) 8 (60) 7 (74)
Dextrose 5% saline
    Interventionb 10 (56) 15 (84) 23 (100) 38 < 0.01
    Control 9 (66) 10 (78) 7 (71)
Pain/fever control
Paracetamol 
    Interventionb 13 (74) 16 (89) 16 (72) 4 0.74
    Control 12 (84) 9 (69) 8 (78)
Pethidine
    Interventionb 1 (3) 0 (0) 2 (11) 9 0.03
    Control 0 (1) 1 (8) 1 (1)
PMTCT drugs
Nevirapine syrup
    Interventionb 12 (68) 15 (82) 20 (86) 24 0.03
    Control 12 (84) 7 (57) 7 (72)
ART regimen 5A
    Interventionb 16 (69) 4 (22) 22 (95) 39 < 0.01
    Control 11 (80) 3 (27) 7 (67)
Ancillary
Urine protein testing strips
    Interventionb 10 (30) 2 (12) 9 (38) 2 0.63
    Control 1 (6) 3 (25) 1 (12)
ART: anti-retroviral treatment; DiD: difference-in-differences estimate; HIV: human immunodeficiency virus; PMTCT: prevention of mother-to-child transmission of HIV.
a  Frequencies are estimates based on regression analysis.
b  The intervention was performance-based financing, a scheme where financial rewards for maternal care providers and district health management teams were 
provided upon meeting defined performance goals (performance-based incentives) with conditional cash transfers (financial rewards) for pregnant women, upon 
meeting defined compliance.
Note: DiD estimates are calculated across years 1 and 2.
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Table 4. Impact of performance based financing on clinical performance of birth attendants, Malawi, 2013–2015
Observed outcome variable by facility type Labour cases with clinical performance 
observed
Overall effect size
Baseline No.a 
(%)
Mid-term 
No.a (%)
End-term No.a 
(%)
DiD (% 
point)
P
Routine obstetric care
Patient’s HIV status checked or reviewed
    Interventionb 46 (73) 65 (61) 77 (59) −4 0.82
    Control 20 (81) 36 (63) 15 (81)   
Patient asked for pre-eclampsia symptomsc
    Interventionb 13 (20) 59 (56) 130 (99) 65 0.12
    Control 17 (71) 26 (45) 16 (86)   
Patient is checked for pre-eclampsia signsd
    Interventionb 39 (62) 106 (100) 88 (67) −1 0.98
    Control 24 (100) 58 (100) 19 (100)   
Monitoring of labour progression during stage 1
Patient monitored by partograph
    Interventionb 42 (66) 65 (61) 80 (61) −24 0.14
    Control 15 (64) 36 (63) 16 (82)   
Complete partograph documentatione on monitored cases
    Interventionb 11 (17) 54 (51) 54 (41) 3 0.86
    Control 1 (6) 7 (11) 5 (28)   
Infection prevention
Hand hygiene before each patient contactf
    Interventionb 18 (28) 34 (32) 49 (37) 12 0.59
    Control 5 (22) 15 (26) 4 (20)   
Sterile glove use during vaginal exam and stage 2      
    Interventionb 34 (53) 67 (63) 95 (72) 12 0.61
    Control 13 (56) 38 (65) 12 (63)   
Decontamination of perineum before vaginal exam and stage 2
    Interventionb 21 (33) 34 (32) 66 (51) 8 0.71
    Control 5 (20) 12 (21) 6 (29)
Birth equipment set up in sterile manner before stage 2 beginsg
    Interventionb 43 (68) 77 (73) 114 (87) 21 0.11
    Control 19 (79) 44 (76) 15 (78)
AMTSL
Medical management of stage 3h
    Interventionb 58 (92) 100 (94) 131 (100) −18 0.17
    Control 16 (68) 51 (87) 18 (94)
Practical management of stage 3i
    Interventionb 45 (72) 83 (78) 112 (85) −24 0.16
    Control 11 (44) 43 (74) 16 (83)
Confirmatory management of stage 3j
    Interventionb 41 (65) 42 (40) 91 (70) −46 0.01
    Control 5 (19) 25 (44) 13 (70)
AMTSL: active management of third stage labour; DiD: difference-in-differences estimate; HIV: human immunodeficiency virus.
a  Frequencies are estimates based on regression analysis.
b  The intervention was performance-based financing, a scheme where financial rewards for maternal care providers and district health management teams were 
provided upon meeting defined performance goals (performance-based incentives) with conditional cash transfers (financial rewards) for pregnant women, upon 
meeting defined compliance.
c  Recent history of headache, blurriness, convulsions, pregnancy-induced hypertension.
d  Blood pressure check, check for swelling or oedema.
e  Defined as documentation of fetal heart rate every 30 minutes, uterine contractions/maternal pulse/maternal blood pressure/fetal descent every 60 minutes.
f  Defined as washing of hands with water and soap.
g  Includes setting up sterile delivery kit contents, sterile cord clamps, sterile gloves.
h  Parenteral administration of oxytocin once stage 3 is entered.
i  Controlled cord traction and uterine massage to actively support delivery of placenta.
j  Placenta examined for completeness and estimation of overall blood loss during delivery to determine woman’s risk of bleeding.
Note: DiD estimates are calculated across years 1 and 2 while controlling for duration of stage 1 labour, number of birth attendants available during a case, number of 
birth attendants’ participation in service trainings, as well as clustering effects at the level of the facility.
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based funding programme that provides 
incentives to central health system levels 
to indirectly support front-line service 
providers.40,41
However, in our study, for some 
items availability did not improve. The 
number of delivery beds, for instance, 
remained unaffected, probably because 
most facilities counted at least two deliv-
ery beds already at baseline. Some drugs 
also remained unchanged (co-trimoxa-
zole, paracetamol) or declined (benzyl 
penicillin, magnesium sulfate, isotonic 
fluids), either indicating increased use 
(e.g. in case of the incentivized ad-
ministration of magnesium sulfate) or 
worsening central drug shortages. A 
randomized-controlled trial from the 
Democratic Republic of the Congo com-
paring performance-based versus fixed 
payments observed significant decline 
in essential equipment availability at 
facilities supported by a performance-
based financing scheme.42 However, in 
this scheme, incentives were provided 
directly to the facility level without in-
cluding district or central level entities.
In our study, Malawi’s nationwide 
economic situation deteriorated before 
our mid-term data collection which may 
have had an effect on drug and con-
sumable stocks. Mixed or inconclusive 
effects were also reported from perfor-
mance-based financing experimental 
work in the Democratic Republic of 
the Congo42 where after the implemen-
tation of the scheme, drug stock-outs 
decreased, though stock-outs of vaccines 
increased. Findings like these point 
towards overall political or economic 
challenges affecting health system and 
performance-based financing scheme 
operations. In contexts where avail-
ability of medical supplies is negatively 
affected by performance-based financ-
ing schemes, a detailed investigation 
may provide further understanding of 
system-wide determinants of perfor-
mance-based financing implementation.
Among those essential drugs whose 
observed availability was not strongly 
affected by the initiative, many (except 
penicillin and Ringer’s lactate) nev-
ertheless remained in stock in more 
than 70% of intervention facilities at 
end-term, which may reflect facilities’ 
new financial autonomy, such as using 
reward earnings to purchase additional 
drugs from private pharmacies. This 
aligns with findings from another 
performance-based financing evalua-
tion in the Democratic Republic of the 
Congo, where facility managers with 
financial autonomy to use performance 
rewards to purchase drugs and supplies 
made decisions resulting in significant 
improvements in drug availability.43 In 
our study, as most of these less avail-
able drugs are essential to the medical 
management of obstetric complications 
(i.e. broad-spectrum antibiotics, crystal-
loid fluids, anticonvulsants), some shifts 
in facility stocks towards second-line 
tracer drugs (i.e. ampicillin, dextrose 
5% saline, diazepam) occurred. These 
shifts likely indicate better strategic 
procurement decisions by district and 
facility managers in response to varia-
tions in first-line drug availability at 
central stores.
Improved availability of some items 
(e.g. blood pressure machines, newborn 
resuscitation equipment, obstetric 
examination beds, diazepam, Ringer’s 
solution) was also observed in control 
facilities. District-level performance 
indicators were purposefully designed 
to introduce spillover benefits to those 
facilities not yet enrolled. Improved 
equipment and supply availability in 
control facilities may represent such pro-
gramme-induced spillover. In addition, 
qualitative evidence from interviews 
with the initiative’s health managers in 
the study districts demonstrate that the 
direct involvement of the district health 
management team led to more frequent 
performance review meetings at district 
levels and closer performance supervi-
sion across facilities.39
Our findings show few positive ef-
fects on clinical processes due to the 
scheme. For pre-eclampsia assessment 
of risk factors, we only observed im-
provements in symptom review, while 
physical examination of clinical signs 
increased only during mid-term data 
collection. There was also no effect 
observed on the routine review of pa-
tients’ HIV status. Mixed effect patterns 
regarding clinical assessment practices 
in maternal and child services, both 
history- and exam-based, were also ob-
served in performance-based financing 
schemes in Afghanistan and Egypt.19,44 
Although less obvious, these findings 
may nevertheless point towards the 
potential the schemes bring to improve 
providers’ adherence to routine care 
standards and clinical guidelines.
In respect to infection prevention 
processes, we observed non-significant 
positive effects on sterile set-up of birth 
equipment, but no effects on hand wash-
ing, use of gloves and perineal cleansing. 
This may reflect a complementary effect 
regarding infection prevention pro-
cesses between clinical performance and 
traced supply incentives, which included 
sterile delivery packs and functional 
sterilizers, but not gloves, topical anti-
septic solutions or other consumables 
relevant to infection prevention. The 
role of complementary use of incentives 
may also explain findings in a study from 
Afghanistan,19 which failed to detect sig-
nificant effects on universal precautions 
in the absence of relevant equipment and 
supply improvements.
We further observed significant 
negative effects on processes related to 
partograph monitoring and AMTSL. As 
oxytocin (tracer item) and partograph 
(not listed as tracer item, but followed by 
the study’s facility inventory) availability 
significantly improved in intervention 
facilities, stock-outs don’t seem to be 
a likely cause of the negative effects. 
The negative trends for AMTSL per-
formance might rather relate to district 
level spillover benefits to control facility 
performance as indicated by qualita-
tive evidence outlining how district 
managers reinforced clinical standards, 
supervision and staff coaching across all 
facilities.39 In the case of AMTSL, con-
trol facilities – starting at a much lower 
performance level, but rapidly catching 
up over time – probably benefitted more 
than facilities in the intervention arm. 
A recent study from Burundi found 
that introduction of a performance-
based financing scheme encourages 
guideline adherence through increased 
supervisory, coaching and technical 
support by senior staff.45 Regarding 
labour monitoring, birth attendants at 
both intervention and control facilities 
improved partograph documentation, a 
relatively time-consuming process. Yet, 
the proportion of overall partograph-
monitored cases stagnated in the inter-
vention facilities, which may simply re-
flect capacity limitations due to staffing 
constraints once service utilization at 
intervention facilities increased.
Our study has some methodologi-
cal limitations. As with other studies on 
quality of clinical care, our sample sizes 
for both facilities and observed cases 
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were relatively small therefore our study 
lacked the statistical power to detect 
additional effects that may have been 
produced by the scheme. Also, due to 
logistical and cost considerations, our 
evaluation design had to rely on control 
facilities within intervention districts, 
falling short in conceptually isolating 
district-level from facility-level effects. 
Our study therefore was not able to dis-
cern whether improvements in control 
facilities represent district-level induced 
spillover or rather resulted from other 
secular trends. ■
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摘要
实施研究以提高马拉维孕产妇及新生儿的卫生保健质量
目的 旨在评估基于绩效的资助计划对马拉维孕产妇及
新生儿卫生服务质量的影响。
方法 我们采用非随机、前后对照的研究方法就地区及
机构级的绩效激励对卫生工作者及管理团队的影响进
行了评估。我们对机构基本药物库存、设备维护及产
科临床护理流程中的变化进行了评估。我们采用回归
模型双重差分析法分析了该计划对遵照产科护理治疗
方案和基本药物供给、用品及设备的影响。
结果 我们在四个地区观察 33 家卫生机构、23 家干预
机构、10 家对照机构以及 401 名孕妇。该计划改善了
干预机构中功能性设备及基本药物库存的供应情况。
我们观察到在非干预机构的药物采购及临床护理活动
方面产生了积极的影响，这可能是由地区管理绩效提
高造成的。地区卫生管理者对临床工作者的的监督及
积极指导提高了所有调查机构的助产人员对临床方案
的依从性。
结论 尽管在全国范围内出现缺货和卫生工作者极度短
缺的现象，但是调查地区中的机构仍设法克服与用品
采购、设备维修及临床表现相关的障碍，提高了孕产
妇及新生儿卫生服务的质量。为了加强和改革卫生管
理结构，基于绩效的资助将可能会是一种有望持续改
善卫生保健的方法。
Résumé
Recherche sur la mise en œuvre, dans une optique d’amélioration de la qualité des soins de santé maternelle et néonatale au Malawi
Objectif Évaluer l’impact, sur la qualité des services de santé maternelle 
et néonatale au Malawi, d’un schéma de financement fondé sur les 
résultats.
Méthodes Nous avons réalisé une étude contrôlée non randomisée 
avant/après afin d’évaluer les effets de mesures incitatives fondées sur 
les résultats, mises en œuvre à l’échelle des districts et des établissements 
de santé à destination des équipes de gestion de la santé et des 
agents de santé. Nous avons ainsi évalué, au sein des établissements 
de santé, l’évolution : des stocks de médicaments essentiels, de la 
maintenance des équipements ainsi que des procédures cliniques en 
صخلم
يولام في ةدلاولا يثيدحو تاهملأل ةيحصلا ةياعرلل ةيعونلا ةدولجا ينستح لىإ ةفدالها ةيذيفنتلا ثاحبلأا
 صالخا  ءادلأا  لىع  دمتعلما  ليومتلا  جمانرب  يرثأت  مييقت  ضرغلا
 يثيدحو  تاهملأل  ةهجولما  ةيحصلا  ةمدخلل  ةيعونلا  ةدولجاب
.يولام في ةدلاولا
 مييقتل ةيدعبو ةيلبق ةيئاوشع يرغ ةمكُم ةسارد ءارجإب انمق ةقيرطلا
 لىع  ةرادلإا  قرفو  يحصلا  لاجلما  في  ينلماعلا  ءادأ  زفاوح  راثآ
 يتلا  تايريغتلا  مييقتب  انمقو .ةيبطلا تآشنلماو تاعطاقلما ىوتسم
 ةنايصو ،ةيبطلا  تآشنلما  في ةيروضرلا يرقاقعلا  نوزمخ لىع تأرط
 جذمان مادختسا مت .ةيريسرلا ةيديلوتلا ةياعرلا تايلمعو ،تادعلما
 مازتللاا لىع جمانبرلا راثآ ليلحتل ”قرافلا في تافلاتخلاا“ فوتح
 ةيروضرلا يرقاقعلا يرفوتو ،ةيديلوتلا ةياعرلا جلاع تلاوكوتوبرب
.تادعلماو دراولماو
 ،لخدت  ةأشنم 23و  ،ةيحص  ةأشنم 33  ةظحلامب  انمق  جئاتنلا
 دقو .قطانم عبرأ  برع لماح ةأرما 401و ،ةيعجرم تآشنم 10و
 نوزمخو  ةيفيظولا  تادعلما  نم  ٍلك  رفوت  ينستح  لىإ  جمانبرلا  ىدأ
 تايلمع  اهيف  تتم  يتلا  ةيبطلا  تآشنلما  في  ةيروضرلا  يرقاقعلا
 ةطشنأو يرقاقعلا ءاشرب قلعتي مايف ةيبايجإ اًراثآ انظحلا ماك .لخدتلا
 ام  وهو  ،لخدتلا  اهيلإ  دتمي  لم  يتلا  تآشنلما  في  ةيريسرلا  ةياعرلا
 مازتلا  نّستحو  .ةقطنلما  ةرادإ  ءادأ  ريوطت  لىإ  حجرلأا  لىع  ىزعُي
 عيجم برع ةيريسرلا تلاوكوتوبرلاب ديلوتلا تايلمع في نيدعاسلما
 لماعأ ميدقت لىإ ةقطنلماب ةحصلا يريدم مادقإ عم ةساردلا تآشنم
.اًطاشن رثكأ لكشب يريسرلا لمعلا مقاوطل بيردتلاو فاشرِلإا
 دالحا صقنلاو نوزخلما صقن تلاكشم نم مغرلا لىع جاتنتسلاا
 تنكتم  دقف  ،دلابلا  ىوتسم  لىع  يحصلا  لاجلما  في  ينلماعلا  في
 ةيحصلا ةمدلخا ةيعون ينستح نم ةساردلا ةقطنم في ةعقاولا تآشنلما
 قانتخلاا لماوع لىع بلغتلا قيرط نع ةدلاولا يثيدحو تاهملأل
 .يريسرلا  ءادلأاو  ،تادعلما  ةنايصو  ،مزاوللا  يرفوتب  ةقلعتلما
 لثمي دقف ،اهحلاصإو ةيحصلا ةرادلإا لكايه زيزعت لىع اًصرحو
 ةمادتسم تانيستح ءارجلإ اًدعاو اًجنه ءادلأا لىع دمتعلما ليومتلا
.ةيحصلا ةياعرلل ةيعونلا ةدولجا في
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soins obstétricaux. Des modèles de régression de l’écart des différences 
ont été utilisés pour analyser les effets de ce schéma sur le respect des 
protocoles de traitement pour les soins obstétricaux et sur la disponibilité 
des équipements, des fournitures et des médicaments essentiels.
Résultats Notre étude a porté sur 33 établissements de santé 
(23 établissements visés par le schéma d’intervention et 10 établissements 
témoins) pour un total de 401 femmes enceintes, dans quatre districts. 
Dans les établissements visés par l’intervention, ce schéma a permis 
d’améliorer la disponibilité des équipements fonctionnels et des stocks 
de médicaments essentiels. Nous avons également observé des effets 
positifs sur l’approvisionnement en médicaments et sur les activités de 
soins cliniques dans les établissements non visés par l’intervention; des 
effets vraisemblablement dus à l’amélioration des performances dans 
la gestion de la santé au niveau des districts. Le respect des protocoles 
cliniques par le personnel obstétrical s’est amélioré dans tous les 
établissements étudiés, grâce à une supervision et à un coaching plus 
actifs du personnel clinique par les responsables de gestion de la santé.
Conclusion Malgré un manque patent d’agents de santé et des 
problèmes de ruptures de stocks qui affectent l’intégralité du pays, les 
établissements des districts étudiés ont réussi à améliorer la qualité 
des services de santé maternelle et néonatale, en surmontant les 
difficultés liées à l’approvisionnement en fournitures, à la maintenance 
des équipements et aux performances cliniques. Pour renforcer et 
réformer les structures de gestion de la santé, le financement fondé sur 
les résultats pourrait constituer une approche prometteuse pour des 
améliorations durables de la qualité des soins de santé.
Резюме
Исследования реализации мероприятий по повышению качества оказания медицинских услуг для 
матерей и новорожденных, Малави
Цель Оценить влияние ориентированной на результат программы 
финансирования на качество услуг, оказываемых материнской и 
неонатальной службой здравоохранения в Малави.
Методы Мы провели нерандомизированное контролируемое 
исследование до начала и после завершения программы, чтобы 
оценить влияние стимулирования медицинских работников и 
команд управления на уровне участка и на уровне медицинского 
учреждения. Мы провели оценку изменений в запасах 
лекарственных препаратов первой необходимости, в проведении 
технического обслуживания оборудования и в клинических 
процессах акушерской помощи в медицинских учреждениях. 
Нами были использованы регрессионные модели «разность 
разностей» для анализа влияния программы на строгое 
соблюдение протоколов акушерской помощи и на обеспечение 
лекарственными препаратами первой необходимости, 
расходными материалами и оборудованием.
Результаты В четырех участках мы поставили под наблюдение 
33 медицинских учреждения, 23 учреждения, осуществляющих 
вмешательство,  10 контролирующих учреж дений и 
401 беременную женщину. Программа повысила доступность 
функционального оборудования и улучшила обеспечение 
лекарственными препаратами первой необходимости в 
учреждениях, осуществляющих вмешательство. Мы наблюдали 
положительный эффект в снабжении лекарственными 
препаратами, а также в лечебной работе в учреждениях, не 
осуществляющих вмешательство, что, вероятно, являлось 
результатом повышения эффективности управления участка. 
Стало более строгим соблюдение клинических протоколов 
акушерами во всех обследованных учреждениях, поскольку 
руководство медицинских учреждений на участках стало более 
активно контролировать и обучать клинический персонал.
Вывод Несмотря на дефицит ресурсов и острую нехватку 
медицинских работников в национальном масштабе, 
медицинским учреждениям на исследуемых участках удалось 
улучшить качество материнского и неонатального медицинского 
обслуживания путем устранения острых проблем, связанных 
с закупками и поставками, техническим обслуживанием 
оборудования и клинической эффективностью. Для укрепления 
и реформирования структуры организации здравоохранения 
финансирование, ориентированное на результат, может быть 
перспективным подходом к устойчивому повышению качества 
оказания медицинских услуг.
Resumen
Investigaciones sobre la ejecución para mejorar la calidad de la atención sanitaria materna y obstétrica, Malawi
Objetivo Evaluar el impacto de un plan de financiación basado en el 
rendimiento en la calidad del servicio sanitario materno y neonatal en Malawi.
Métodos Se realizó un estudio controlado no aleatorizado del antes 
y el después para evaluar los efectos de los incentivos de rendimiento 
a nivel de distritos y de centros para trabajadores sanitarios y equipos 
de administración. Se evaluaron los cambios en las existencias de 
medicamentos esenciales, el mantenimiento del equipo y el proceso 
de atención obstétrica clínica en los centros. Se utilizaron modelos 
de regresión de diferencia en diferencia para analizar los efectos del 
plan sobre la adherencia a los protocolos de tratamiento de atención 
obstétrica y el suministro de medicamentos esenciales, suministros y 
equipos.
Resultados Se observaron 33 centros sanitarios, 23 centros de 
intervención y 10 centros de control y 401 mujeres embarazadas 
en cuatro distritos. El plan mejoró la disponibilidad de los equipos 
funcionales y de las existencias de medicamentos esenciales en los 
centros de intervención. Se observaron efectos positivos en cuanto a 
la adquisición de medicamentos y actividades de atención clínica en 
centros de no intervención, posiblemente en respuesta a un mejor 
rendimiento de la administración de distritos. La adherencia de los 
asistentes de parto a los protocolos clínicos mejoró en todos los centros 
estudiados, dado que los gestores sanitarios de los distritos supervisaron 
y formaron de forma más activa al personal clínico.
Conclusión A pesar de la falta de existencias en todo el país y la extrema 
escasez de trabajadores sanitarios, los centros de los distritos estudiados 
lograron mejorar la calidad del servicio sanitario materno y neonatal, 
pues superaron todos los obstáculos relacionados con la adquisición 
de productos, el mantenimiento de los equipos y el rendimiento 
clínico. Para fortalecer y reformar las estructuras de gestión sanitaria, 
una financiación basada en el rendimiento podría ser un enfoque 
prometedor para obtener grandes mejoras en la calidad de la atención 
sanitaria.
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